Studies suggest possible future treatments to reverse Parkinson's

Scientists have found 'vital new evidence' towards halting the progression of Parkinson's disease, after an animal model study found that drugs could reverse problems arising from genetic defects.

MRI scan of a brain showing Parkinson's disease (Photo: Science Photo Library)
MRI scan of a brain showing Parkinson's disease (Photo: Science Photo Library)

Mutations in the LRRK2 gene in humans are known to be the most common genetic contributor to Parkinson’s disease, although the mechanisms have been poorly understood.

But in tests on in vitro rat neurons, University of Sheffield researchers found that these mutations interfere with how vital proteins and minerals are transported across nerve cells, causing impaired motor functions.

The study, published in Nature, also looked at fruit flies with faulty copies of the LRKK2 gene. It found that by targeting the transport system in these neurons with specific drugs, these defects could be reversed, thereby alleviating Parkinson’s disease-like symptoms in the flies.

'Rescue effect' for patients

The drugs, known as deacetylase inhibitors, work by restoring normal transport along the faulty neurons and therefore could have a ‘rescue effect’ in affected cells.

Study author Dr Alex Whitworth said: ‘By targeting the transport system with drugs, we could not only prevent movement problems, but also fully restore movement abilities in fruit flies who already showed impaired movement marked by a significant decrease in both climbing and flight ability.’

The authors concluded that the ‘very promising results’ show that drug treatments ‘may have therapeutic potential’ for treating humans with Parkinson’s, although much more research will be needed to see if the effects could be replicated outside of animal tests.

Dr Beckie Port, from Parkinson’s UK, which helped to fund the study, said: ‘This research gives hope that, for people with a particular mutation in their genes, it may one day be possible to intervene and stop the progression of Parkinson’s.’

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Follow Us:

Just published

Boris Johnson, Sajid Javid and NHS chief executive Amanda Pritchard at Downing Street press conference

GPs offered £15 per jab as government sets 31 January COVID-19 booster deadline

COVID-19 vaccine payments to GP practices will rise nearly a fifth to £15 per jab...

Houses of parliament

Evidence for mandatory NHS staff COVID-19 jabs 'not good enough', says Lords committee

Evidence to support government plans to require all NHS staff in patient-facing roles...

Dr Farah Jameel

Practices 'need substantial support' to step up Omicron response, warns BMA GP chair

General practice is already facing unsustainable pressure and will need 'substantial...

JCVI COVID-19 immunisation chair Professor Wei Shen Lim

JCVI backs immediate expansion of COVID-19 vaccination to combat Omicron variant

The COVID-19 booster campaign should expand immediately to people aged 18-39 and...

Close up of hand holding sample tube with 'Omicron' handwritten on side

Government urged to 'free up' GP practices and expand steps to control Omicron

GPs have called for immediate action such as suspension of QOF to allow practices...

(Photo: Mike Kemp/Getty Images)

Coronavirus: Key guidance GPs need to know about COVID-19

GPonline provides an overview of the key guidance relating to coronavirus, including...